Antagonists in the homobenzomorphan series.
D000535:Aluminum; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D003488:Cyanogen Bromide; D003640:Dealkylation; D006868:Hydrolysis; D007928:Lethal Dose 50; D007977:Levallorphan / Q000494:pharmacology; D008094:Lithium; D051379:Mice; D009019:Morphinans / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D009020:Morphine / Q000037:antagonists & inhibitors; D009269:Nalorphine / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D010084:Oxidation-Reduction; D010423:Pentazocine / Q000494:pharmacology; D011804:Quinolines / Q000138:chemical synthesis; D013329:Structure-Activity Relationship
D000700:Analgesics; D009019:Morphinans; D009292:Narcotic Antagonists; D011804:Quinolines; D007977:Levallorphan; D009020:Morphine; D008094:Lithium; D000535:Aluminum; D003488:Cyanogen Bromide; D010423:Pentazocine; D009269:Nalorphine